Institutional Decoupling and the Economics of Financial Reporting: Evidence from Nigeria's Pharmaceutical Sector

Endurance Sani Aferokhe, Joan Onyinyechi Njoku, James Apemiye and Chigozie Kennedy Uzoh
Additional contact information
Endurance Sani Aferokhe: Department of Accountancy, University of Nigeria, Nsukka, Enugu, Enugu State, Nigeria.
Joan Onyinyechi Njoku: Department of Accountancy, University of Nigeria, Nsukka, Enugu, Enugu State, Nigeria.
James Apemiye: Department of Management, Godfrey Okoye University, Enugu State, Nigeria.
Chigozie Kennedy Uzoh: Department of Business Administration, Kingsley Ozumaba Mbadiwe University, Ideato, Imo State, Nigeria.

Post-Print from HAL

Abstract: This study investigates whether corporate governance mechanisms constrain earnings management among listed pharmaceutical firms in Nigeria through the lens of institutional decoupling. The analysis covers 2015–2025 and uses a census of seven firms, yielding 58 firm-year observations. Discretionary accruals are estimated with the performance-adjusted Modified Jones Model, while the effects of board size, board independence, audit committee independence, and board gender diversity are examined using fixed-effects panel regression. Firm size and financial leverage are included as control variables. The results indicate that none of the four governance attributes has a statistically significant effect on discretionary accruals. Firm size is the only significant determinant at the 5% level and has a positive coefficient, consistent with the political cost hypothesis, whereas financial leverage is insignificant. A pooled ordinary least-squares sensitivity analysis similarly shows that the governance variables remain insignificant. These findings indicate that formally adopted governance structures may not translate into effective monitoring within the studied setting. The evidence is therefore consistent with institutional decoupling, whereby compliance with governance requirements may be more ceremonial than substantive. The study highlights the importance of assessing board processes, expertise, and monitoring performance rather than relying only on structural indicators. It also suggests that regulators and investors should evaluate the practical effectiveness of governance arrangements when assessing financial reporting quality in Nigeria's pharmaceutical sector.

Date: 2026-08-12
References: Add references at CitEc
Citations:

Published in Asian Journal of Economics, Business and Accounting, 2026, 26 (8), pp.183-195

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-05716368

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().